Search Results (296)

Geroprotective molecules are currently being actively investigated for the prevention of skin aging. An overview of geroprotectors in dermatology encompasses agents such as antioxidants, ultraviolet (UV) photoprotective agents, chemical peels, and carbon dioxide (CO₂) lasers, each with inherent limitations, including poor tolerability in individuals with sensitive skin. Regarding biostimulators, high-molecular-weight peptides (exceeding 500 kDa) exhibit limited cutaneous bioavailability, underscoring the need for low-molecular-weight geroprotective compounds. One such candidate is dehydroepiandrosterone DHEA, a neurosteroid with anti-aging and anti-stress properties, which also serves as a precursor to sex steroids. Although topical hormone replacement therapy with estrogens and androgens is being utilized, it remains confined to formal hormone replacement regimens and is associated with a significant adverse effect profile. The aim of this review was to analyze the key molecular mechanisms underlying the effects of DHEA on the skin, with particular emphasis on its metabolism and sex- and age-dependent mechanisms of action. Additionally, this review seeks to elucidate the factors contributing to the absence of approved topical DHEA formulations and to outline the potential of DHEA as an anti-aging agent in dermatological applications. DHEA has demonstrated significant skin-improving effects in several studies; its investigation has been predominantly confined to postmenopausal women. Furthermore, the outcome measures employed in these studies lacked specificity. DHEA is not permitted for use in cosmetic products within the European Union due to its hormonal activity. Its use is only allowed as an extemporaneous formulation under the established regulatory frameworks of individual countries. The indications for its use and the appropriate dosage for men and women must be clearly defined based on the results of future clinical studies. Promising research directions include the pharmacogenetic characterization of steroidogenic enzymes and sex hormone receptors, as well as the evaluation of DHEA in both sexes, specifically in premenopausal women and in men presenting with late-onset hypogonadism. Additionally, the biological effects of the primary metabolites of DHEA, androstenedione, and 5-androstenediol, on the cutaneous function remain unexplored, including their potential anti-aging activity mediated through retinoid receptor activation. Full article

Black mustard (Brassica nigra L.) seeds are a rich source of bioactive phytochemicals; however, their antioxidant, antibacterial, and anti-inflammatory potential has not been comprehensively explored. Therefore, this study aimed to assess antioxidant, antibacterial, and anti-inflammatory effects of black mustard seed extracts obtained from Soxhlet extraction with hexane (HE) and ethanol (EE), and ultrasonic-assisted ethanolic (UE) extraction. HPLC analysis confirmed the presence of sinapic acid in all extracts. Phytochemical profiling revealed that the EE was enriched in phenolic compounds, while the UE exhibited a higher flavonoid content. Accordingly, both EE and UE demonstrated strong antioxidant activities, including radical scavenging capacity, reducing power, and inhibition of lipid peroxidation. All extracts demonstrated antibacterial activity against Staphylococcus epidermidis. The anti-inflammatory potential of extracts was supported by the inhibition of lipoxygenase and protease. The UE showed the strongest lipoxygenase inhibition, while the EE and UE exhibited comparable protease inhibitory effect. Regarding RAW264.7 cells, the extracts were non-cytotoxic and reduced the expression of IL-6 and IL-31. Molecular docking analysis suggested that sinapic acid contributes to the anti-inflammatory activity through interactions with key inflammatory targets. Overall, the EE and UE demonstrated multitarget antioxidant, antibacterial, and anti-inflammatory activities, supporting their potential application in functional and dermatological formulations for inflammation management. Full article

The demand for eco-friendly photoprotection has increased due to the observed adverse effects of conventional UV filters on marine ecosystems. In this study, we developed a broad-spectrum, reef-friendly sunscreen emulsion containing Perilla frutescens seed extract. The extraction process was optimized using 95% ethanol maceration for one week, yielding the highest SPF of 22.61. Gas chromatography–mass spectrometry (GC-MS/MS) was used to identify linolenic acid (43.54%) as the predominant fatty acid. Cytotoxicity test results for HaCaT keratinocytes were used to confirm the extract’s safety, with an IC₅₀ of 12.9 mg/mL. The formulated sunscreen met environmental safety standards based on persistence, bioaccumulation, and toxicity (PBT) criteria. A clinical safety evaluation using a 24 h closed patch test (n = 17) demonstrated that the formulation induced no significant alterations in TEWL or erythema levels (p > 0.05), confirming its dermatological safety. In a clinical efficacy evaluation involving 30 volunteers, the formulation containing 1% perilla extract reduced both erythema values and the melanin index, with no statistically significant difference observed (p > 0.05). These findings demonstrate that P. frutescens seed extract is a potent bioactive ingredient for sustainable cosmeceuticals, offering effective sun protection while ensuring safety for both human skin and marine environments. Full article

The genus Alchornea Sw. belongs to the Euphorbiaceae family. Alchornea species are commonly used in traditional medicine to treat inflammation; infectious, gastrointestinal, respiratory, musculoskeletal, and dermatological disorders; as well as other diseases. This comprehensive review provides an overview of recent scientific findings on the taxonomy, ethnomedicinal uses, phytochemistry, pharmacological potential, and toxicology of the Alchornea species. The literature was searched using SciFinderⁿ, Google Scholar, and PubMed. The taxonomy of all reported plants was authenticated using “Plants of the World Online”. Studies were examined and categorized according to the genus’s taxonomic classification, traditional uses, phytochemistry, pharmacological potential, and toxicity. Phytochemical studies have identified 396 bioactive compounds, primarily triterpenoids, alkaloids, flavonoids, and phenolics. Pharmacological studies have reported significant antimicrobial, anti-inflammatory, antioxidant, anti-plasmodial, and cytotoxic effects. Nevertheless, toxicological statistics are limited and vary among species and extracts. The genus Alchornea exhibits significant pharmacological potential, as evidenced by its traditional uses. In comparison, the genus remains underexplored in terms of detailed mechanistic pharmacological evaluation. Studies of chemical constituents and biological activities have been conducted for only approximately 17 species. To translate the pharmacological potential of the genus Alchornea into clinical practice, a strategic focus on modern plant valorization is required. Future research should focus on the valorization of Alchornea species by developing standardized oral formulations and topical preparations that harness their validated anti-inflammatory and antimicrobial effects beyond traditional uses. However, these findings suggest that further research is needed to assess the efficacy and safety of the largely unexplored genus Alchornea. Full article

Background/Objectives: The efficacy of topical therapies in dermatology is often limited by the barrier function of the stratum corneum, which restricts drug penetration. Iontophoresis is a non-invasive transdermal delivery technique that uses a low-intensity electrical current to enhance the transport of charged and polar molecules across the skin. It has emerged as a strategy to improve local drug bioavailability while minimizing systemic exposure. We systematically reviewed the clinical evidence on the efficacy, safety, and pharmacologic performance of iontophoresis-assisted topical drug delivery in dermatologic diseases. Methods: This systematic review followed PRISMA guidelines and was prospectively registered in PROSPERO (CRD420251234877). PubMed, Embase, Web of Science, CENTRAL, and ClinicalTrials.gov were searched through 19 November 2025 without language restrictions. Records were screened against predefined eligibility criteria, and data were extracted on study design, participants, dermatologic indications, intervention/comparator, iontophoresis parameters, efficacy outcomes, and adverse events. The risk of bias was assessed using RoB 2 for randomized trials and the JBI checklist for non-randomized studies. Because of substantial clinical and methodological heterogeneity, the findings were synthesized narratively and no meta-analysis was performed. Results: Twenty-one studies published between 1990 and 2025 met the inclusion criteria, including 15 randomized and 6 non-randomized studies. Investigated conditions included psoriasis, eczema, melasma, post-inflammatory hyperpigmentation, herpes labialis, onychomycosis, chronic ulcers, systemic sclerosis-related digital ulcers, acne scarring, and actinic keratosis. Across studies, findings were mixed. The most consistent signals of benefit were observed in pigmentary disorders and infectious diseases, whereas results were more heterogeneous in inflammatory dermatoses and some studies did not show superiority over active comparators. Tolerability was generally favorable, with adverse events limited to mild, reversible local reactions such as erythema, tingling, burning, or transient irritation. No serious treatment-related adverse events were reported. Conclusions: Iontophoresis may represent a useful non-invasive delivery-enhancement strategy in selected dermatologic settings, particularly when topical efficacy is limited by anatomical or physicochemical barriers. However, heterogeneity in protocols, formulations, outcomes, and clinical indications limits direct comparison and does not support broad conclusions of efficacy across all dermatologic conditions. Larger, standardized trials are needed to clarify its therapeutic role, long-term efficacy, and indication-specific benefit. Full article

Background: The skin, as the largest organ of the human body, plays a crucial role in protection, immunity and homeostasis. Its exposure to environmental and internal factors contributes to the development of various dermatological conditions. Conventional treatments are often associated with adverse effects and increased resistance. This review aims to explore the growing role of phytotherapeutic approaches in dermatology, along with mapping recent research trends in the field. Methods: The paper presents three parts: the first part highlights the mapping of interest in the addressed topic through a systematic selection of the specialized literature using the Web of Science database. A bibliometric analysis was conducted using the Web of Science Core Collection, with data visualized in VOSviewer to identify publication trends, keyword clusters, and collaboration networks across European countries. Subsequently, in the second part of the review, the main topical topics regarding the skin were addressed (the immune and non-immune response system, microbiome composition and physiological responses in different situations). The third part of the paper addresses phytotherapy targeted at the dermatological sphere and controlled release therapeutic systems. Results: The analysis identified a total of 267 publications, with a significant increase in recent years. Key research clusters included phytochemical-based therapies, nanocarrier systems, and inflammatory skin conditions. Keyword co-occurrence analysis revealed emerging trends in nanoformulations and targeted delivery systems. The main research groups focused on polyphenols, antioxidant activity, anti-inflammatory effects and advanced delivery systems, such as nanoparticles and liposomes. In addition, innovative formulations have improved bioavailability and targeted administration. Conclusions: Phytotherapeutic approaches represent a promising alternative to conventional dermatological treatments, offering effective, safer and more sustainable solutions. The integration of natural compounds with modern delivery systems improves therapeutic outcomes and minimizes side effects, supporting their increasing relevance in clinical and pharmaceutical research. Full article

The environmental burden from cosmetic production has intensified interest in sustainable and scientifically robust raw materials. Among the emerging alternatives, agro-industrial residues are gaining attention as chemically rich sources of bioactive compounds with potential for dermocosmetic applications. However, research on their molecular activity, formulation performance, and industrial feasibility remains fragmented across the fields of sustainability, dermatology, and engineering. This narrative review synthesizes current knowledge on the phytochemical composition of extracts from agro-residues. It also critically examines their effects on key skin-related pathways, including oxidative stress modulation, extracellular matrix regulation, inflammation, senescence, and barrier function. Compounds such as polyphenols, carotenoids, peptides, and polysaccharides have been reported to influence signaling networks, including Nrf2/ARE, NF-κB, TGF-β/Smad, and PI3K/AKT/mTOR. Importantly, most of this evidence originates from in vitro and ex vivo studies on animal models, while controlled human and clinical studies remain limited; thus, mechanistic findings should not be equated with proven dermocosmetic efficacy. Nevertheless, challenges remain, such as compositional variability, safety-validation requirements, limited skin bioavailability and stability of bioactives in finished formulations, and limitations in scalable green extraction. Economic modeling and life-cycle assessment also highlight the need to verify both financial and environmental viability. Advancing agro-residue-derived bioactives toward mainstream cosmetic use will require strategies that integrate molecular characterization, regulatory alignment, rigorous claims substantiation and sustainable process optimization. Full article

Acne vulgaris is a chronic inflammatory disease of the pilosabaceous unit with a multifactorial pathogenesis involving sebaceous gland activity, follicular hyperkeratinization, microbial dysbiosis, and immune dysregulation. Increasing attention has been given to the role of the skin and gut microbiome, as well as the gut–skin axis, although their clinical significance has not yet been fully explained. This review critically evaluates the current evidence regarding the use of probiotics, prebiotics, and synbiotics in the treatment of acne. Available studies suggest that microbiome-targeted interventions may influence inflammatory pathways, microbial composition, and metabolic regulators such as IGF-1 and mTORC1. Some clinical trials indicate improvements in acne severity and skin parameters following oral or local interventions. However, the evidence is heterogeneous and limited by small sample sizes, short study durations, and variability in formulations and outcomes. Therefore, although microbiome-based strategies may have potential as adjunctive therapy, their clinical efficacy remains uncertain. Further, well-designed, large-scale studies are needed to determine their role in dermatological practice. Full article

Cutaneous disorders such as atopic dermatitis, psoriasis, acne vulgaris, and rosacea, together with UV-induced skin injury and photoaging, are highly prevalent conditions that involve varying contributions from dysregulated immune responses, cutaneous inflammation, oxidative stress, barrier dysfunction, microbiome alteration, and exogenous injury. However, these conditions are biologically heterogeneous and should not be regarded as a single mechanistic class. Sulforaphane, a naturally occurring isothiocyanate found primarily in broccoli and other cruciferous vegetables, has attracted interest in dermatology because of its antioxidant, cytoprotective, and context-dependent anti-inflammatory properties. Sulforaphane exerts its biological effects by modulating key signaling pathways, particularly the Keap1/Nrf2 pathway and, in some settings, NF-κB-related signaling, thereby reducing oxidative stress and inflammation, regulating immune responses, enhancing skin barrier function, and potentially influencing the cutaneous microbiome. Preclinical studies and limited human data suggest that sulforaphane may reduce erythema, edema, and other markers of cutaneous damage in selected settings. This comprehensive review explores the role of sulforaphane across heterogeneous cutaneous conditions, with emphasis on molecular mechanisms, disease-specific differences, current evidence, and discusses key translational constraints including formulation, delivery, lack of standardized dosing, and the limitations of cell culture and animal models for predicting human efficacy. Overall, sulforaphane should presently be regarded as a promising but still early-stage translational candidate in dermatology. Robust human efficacy data remain lacking for chronic inflammatory dermatoses such as psoriasis, atopic dermatitis, acne, and rosacea, whereas the strongest current human evidence relates to UV-associated skin outcomes and photoprotection. Full article

Background/Objectives: Among the Inflammatory Skin Diseases (ISDs), psoriasis represents a recalcitrant and disabling dermatological disorder associated with perpetuated inflammatory conditions. Recent findings showed that psoriasis pathogenesis is sustained by the interplay of different inflammatory Signaling Pathways, among which the JAK/STAT stands out. Methods: This review aims to investigate the state of the art and the most recent insights concerning the efficacy of plant extracts in psoriasis management via modulation of the JAK/STAT Signaling Pathway. Results: In vitro and in vivo studies revealed that several different plant species showed promising results in modulating the dysregulation of the JAK/STAT Signaling Pathway associated with psoriasis. Raw and enriched extracts and herbal remedy formulations were discussed. Then, present insights, future directions, and gaps of literature were addressed. Conclusions: Promising studies suggested that plant-based products, able to downregulate the JAK/STAT Signaling Pathway, could represent an effective tool for psoriasis management. Full article

Astaxanthin (AST) is a carotenoid with powerful antioxidant and anti-inflammatory properties and increasing interest in dermatological and nutraceutical applications. In this study, AST-rich extracts were obtained from by-products of the blue crab Callinectes sapidus and chemically characterized using HPLC-DAD analysis. The antioxidant activity of the extracts was assessed through complementary spectrophotometric assays (DPPH and FRAP). Comparable AST contents were detected in the two extracts, with values of 1.269 ± 0.006 and 1.219 ± 0.015 mg/100 g dry weight for EtOH and IPrOH, respectively. However, the EtOH extract exhibited higher antioxidant activity, reaching 0.10 ± 0.01 mg Trolox equivalents (TE)/g in the DPPH assay and 0.27 ± 0.02 mg TE/g in the FRAP assay, compared with 0.08 ± 0.01 and 0.11 ± 0.03 mg TE/g for the IPrOH extract. The biological activity of AST extracts was further evaluated against the opportunistic pathogen Staphylococcus aureus and beneficial lactic acid bacteria. AST exhibited moderate antibacterial activity against S. aureus, with an MIC value of 50 μg/mL and inhibition zones up to 14 mm at 200 μg/disc, while promoting the proliferation of Lactobacillus plantarum, Lactobacillus casei, and Lactobacillus reuteri. These findings highlight the prospective valorization of blue crab by-products as a sustainable supply of antioxidant and microbiota-modulating compounds with possible applications in skin health and cosmetic formulations. Full article

The skin–brain axis constitutes a complex, bidirectional network integrating cutaneous sensory, immune, and neuroendocrine systems with central neural circuits involved in emotion regulation, stress responsivity, and social cognition. Advances in psychodermatology and cosmetic science have progressively extended this framework to the emerging field of neurocosmetics, which explores how topical formulations, sensorial properties, and cutaneous neuromodulators may influence psychological well-being, affective states, and perceived stress. The aim of this narrative review is to synthesize current evidence on the biological foundations of the skin–brain axis and to critically examine the implications of these mechanisms for neurocosmetic interventions from a psychological and psychiatric perspective. It describes the biological substrates underlying skin–brain communication, including the cutaneous hypothalamic–pituitary–adrenal axis, neuropeptides, neurotrophins, transient receptor potential channels, and endocannabinoid signaling, and examines how these pathways are targeted by neurocosmetic interventions. Particular attention is devoted to neuroactive compounds, such as peptides, cannabinoids, botanicals, and aromatherapeutic molecules, as well as to sensorial strategies involving texture, temperature, and olfactory cues, which may modulate mood, anxiety, and self-perception through peripheral mechanisms. From a psychological and psychiatric perspective, the review discusses the intersection between stress-related skin conditions, body image disturbances, and emotional dysregulation, highlighting how cosmetic practices may influence subjective well-being beyond purely aesthetic outcomes. Methodological limitations of the existing literature, including the heterogeneity of study designs and outcome measures, as well as ethical considerations related to mood- and stress-related claims in cosmetic products, are critically examined. Finally, future research directions are outlined, and a translational framework is proposed to integrate dermatology, neuroscience, and mental health within next-generation cosmetic science. Full article

Sustainable sourcing of bioactive ingredients is an important direction in the development of topical formulations. Fruit by-products generated during food processing such as apple pomace, represent a promising resource for skincare applications. The aim of this study was to evaluate the safety, effectiveness, and consumer perception of a three-step facial skincare regimen consisting of a cleansing gel, serum, and face cream containing upcycled apple pomace extract. Unlike most cosmetic studies focusing on single products, this research assessed a complete skincare routine to better reflect real-life usage conditions. All formulations underwent dermatological safety evaluation prior to the in vivo study. The clinical assessment was conducted on 30 healthy female volunteers aged 25–55 years. Skin hydration, pH, transepidermal water loss, sebum level, and skin gloss were measured on untreated skin, after the first use, and after four weeks. User perception was assessed using a questionnaire completed by 58 participants. Short-term changes in skin parameters were observed after application, while four weeks of use maintained them within physiological ranges. Skin gloss increased significantly by 4.2%, and no adverse reactions were reported. These results indicate that the tested skincare regimen containing apple pomace extract was well-tolerated and cosmetically acceptable under the study conditions. Full article

This narrative review examines topical anti-inflammatory therapies in veterinary medicine through the lens of the One Health framework, integrating pharmacology, dermatology, ecotoxicology, food safety, and regulatory science. It discusses the interconnected roles of veterinarians, pharmacists, environmental scientists, public health authorities, and regulatory bodies in addressing antimicrobial resistance, environmental contamination, zoonotic transmission, and drug residues in food-producing animals. By emphasising cross-sector collaboration, the review highlights how coordinated strategies can enhance animal welfare, safeguard human health, and reduce ecological burden. The article analyses inflammatory conditions in companion and farm animals and compares systemic versus topical anti-inflammatory approaches. Particular attention is given to corticosteroids, NSAIDs, immunomodulators, pro-resolving lipid mediators, and plant-derived bioactives, alongside advances in vehicles such as lipid nanocarriers and biodegradable film-forming systems designed to minimise systemic absorption and environmental dispersion. Regulatory considerations, residue control, pharmacovigilance gaps, and sustainability-oriented formulation strategies are critically addressed. Topical anti-inflammatory therapies, when rationally designed and monitored under One Health principles, represent a strategic opportunity to improve therapeutic precision while limiting systemic toxicity and ecological impact. Future directions should prioritise translational research, eco-compatible formulation design, and harmonised regulatory frameworks. Full article

Background: Retinoids are established as a cornerstone in the management of photoaging; however, their clinical utility is frequently limited by local irritation, leading to poor patient compliance. This study evaluates the efficacy and safety of a new retinol formulation designed to improve skin texture and wrinkles while minimizing adverse effects. Methods: A prospective, rater-blinded pilot clinical study was conducted involving 21 women with moderate-to-severe photoaging over a 180-day period. Participants followed a progressive application protocol using a specific retinol emulsion alternating with a replenishing cream. Efficacy was assessed using the validated Rao–Goldman scale and VISIA^® image analysis, while safety was monitored through the reporting of adverse events (AEs) and dermatological evaluations. The primary endpoint was the percentage of patients achieving a Rao–Goldman score of 2 at day 180. Results: A statistically significant improvement on the Rao–Goldman scale was observed, with 76.2% of patients improving from their baseline classification to exhibit only fine wrinkles (Grade 2) (p = 0.028). Instrumental analysis was performed using the VISIA^® system. Regarding safety, although 81% of participants initially reported adverse effects such as erythema and scaling, these incidents decreased significantly over time. Conclusions: The novel retinol formulation demonstrates significant clinical efficacy in ameliorating the signs of photoaging, while maintaining a favorable safety profile Full article